General characteristics and body transformation
The medication Bromhexinum is well known under the brand names Solvin and Bisolvon. The main feature of its pharmacokinetics is that the substance is a prodrug. Upon entering the human body, it undergoes metabolic transformations resulting in the formation of a pharmacologically active metabolite — ambroxol.
Pharmacodynamics features
The pharmacological effects of the drug are due to its ability to thin secretions and facilitate their elimination. In addition to the main mucolytic action realized through the formation of ambroxol, Bromhexinum exhibits its own specific antitussive action.
Clinical application and routes of administration
The key indications for prescription are various pathological conditions of the respiratory system accompanied by difficult expectoration of viscous sputum:
- Bronchitis and tracheobronchitis
- Pneumonia
- Bronchiectasis
- Bronchial asthma
Various routes of administration are used to deliver the drug into the body: oral administration (in the form of tablets and solutions), and in the most severe cases, intravenous administration is used.
Safety profile
Overall, the medicinal product is characterized by good tolerability by patients. However, possible adverse reactions should be considered in medical practice:
- Allergic manifestations — skin rash or rhinitis.
- Dyspeptic disorders — may occur with prolonged course administration of the drug.
Briefly: answers to topical questions
What is the biochemical mechanism of the mucolytic action of bromhexine?
Bromhexine is a prodrug whose mechanism of action is associated with biotransformation in the body into the active metabolite — ambroxol. The main pharmacodynamic effects of the drug include:
- Sputum thinning — reducing the viscosity of bronchial secretions to facilitate their elimination.
- Stimulation of surfactant synthesis — production of surface-active substance.
In addition to mucolytic and expectorant effects, the drug possesses its own antitussive action. It is used orally or intravenously for diseases with difficult expectoration of viscous sputum.
What are the absolute contraindications to prescribing bromhexine?
Contraindications to prescribing bromhexine include pregnancy and the breastfeeding period. For drugs containing bromhexine or ambroxol, a contraindication during pregnancy in the first trimester and during breastfeeding is separately indicated. These restrictions also apply to combination drugs containing bromhexine, guaifenesin, and salbutamol.
Which drug groups are contraindicated to combine with bromhexine?
Bromhexine is strictly contraindicated to combine with antitussive agents. Since bromhexine is an expectorant and mucolytic agent that promotes sputum clearance, suppression of the cough reflex is unacceptable. Antitussive agents that cannot be combined with bromhexine include:
- Glaucine — a centrally acting drug (non-narcotic).
- Prenoxdiazine — a peripherally acting drug.
- Oxeladine — an agent that suppresses the cough reflex.
- Codeine — a centrally acting drug (narcotic).
How does bromhexine affect the production of endogenous surfactant?
Bromhexine stimulates surfactant production. This effect is also characteristic of its active form — ambroxol. Surfactant prevents alveolar collapse and possesses bactericidal properties.
Bromhexine is converted into Ambroxol: BA (Bromhexine -> Ambroxol).
Class and exam questions
Is bromhexine an active substance in its own right?
No, the substance acts as a prodrug. It exhibits its main pharmacological properties after conversion into its active metabolite, ambroxol.
What are the main effects of this drug?
It exerts a pronounced mucolytic and expectorant effect, and also possesses its own antitussive effect.
In what clinical situations is Bromhexine prescribed?
It is used for diseases accompanied by difficult expectoration of viscous sputum: bronchitis, tracheobronchitis, pneumonia, bronchiectasis, and bronchial asthma.
What are the possible side effects with prolonged use?
Allergic reactions, such as skin rash and rhinitis, are possible, and dyspeptic disorders may also develop with prolonged use.
What else to study on this topic
- Mechanism of metabolic transformation of bromhexine to ambroxol at the enzymatic level
- Comparative analysis of the mucolytic activity of bromhexine and other secretolytics
- Pharmacokinetic features of oral and intravenous routes of administration
- Patient management tactics in case of dyspeptic disorders during long-term therapy
- Criteria for choosing between bromhexine and pure ambroxol in clinical practice
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Bromhexine" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section 'Drugs acting on respiratory system functions'
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.